The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases (Q36162523)

12 August 2017

The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases (English)

1 reference

12 August 2017

0 references

1 reference

Anja Hviid Simonsen

0 references

Inês Baldeiras

0 references

Sylvain Lehmann

0 references

Marcel M Verbeek

0 references

José L Molinuevo

0 references

Philip Scheltens

1 reference

12 August 2017

Henrik Zetterberg

1 reference

12 August 2017

Kaj Blennow

1 reference

12 August 2017

Walter Maetzler

1 reference

12 August 2017

Bengt Winblad

1 reference

12 August 2017

Charlotte E Teunissen

1 reference

12 August 2017

Brit Mollenhauer

1 reference

12 August 2017

Magda Tsolaki

1 reference

12 August 2017

Fay Betsou

1 reference

12 August 2017

Lucilla Parnetti

1 reference

12 August 2017

Frans R J Verhey

1 reference

12 August 2017

Tormod Fladby

1 reference

12 August 2017

Lutz Froelich

1 reference

12 August 2017

Luka Kulic

1 reference

12 August 2017

Piotr Lewczuk

1 reference

12 August 2017

Frederic Brosseron

1 reference

12 August 2017

Enrica Cavedo

1 reference

12 August 2017

Tomasz Gabryelewicz

1 reference

12 August 2017

Alberto Lleó

1 reference

12 August 2017

Pieter Jelle Visser

1 reference

12 August 2017

Elisabeth Kapaki

1 reference

12 August 2017

Babette L R Reijs

1 reference

12 August 2017

Nikolai Goncharenko

1 reference

12 August 2017

Hakan Gurvit

1 reference

12 August 2017

Peter Koson

1 reference

12 August 2017

Alexandre de Mendonça

1 reference

12 August 2017

Anne-Marie Miller

1 reference

12 August 2017

Uros Rot

1 reference

12 August 2017

Anja Schneider

1 reference

12 August 2017

Fabrizio Tagliavini

1 reference

12 August 2017

Marzena Zboch

1 reference

12 August 2017

language of work or name

1 reference

15 October 2015

1 reference

12 August 2017

Frontiers in Neurology

1 reference

12 August 2017

1 reference

12 August 2017

216

1 reference

Variability of CSF Alzheimer's disease biomarkers: implications for clinical practice

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4606063

Biobanking of CSF: international standardization to optimize biomarker development

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4606063

Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4606063

Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4606063

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4606063

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4606063

Quantification of α-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4606063

Standardization of Assay Procedures for Analysis of the CSF Biomarkers Amyloid β((1-42)), Tau, and Phosphorylated Tau in Alzheimer's Disease: Report of an International Workshop

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4606063

Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4606063

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4606063

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4606063

Diagnostic criteria for Parkinson disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4606063

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4606063

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4606063

Dementia of frontal lobe type

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4606063

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4606063

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4606063

A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4606063

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4606063

Cerebrospinal fluid amyloidβ peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: Indication of carrier-mediated epitope masking of amyloidβ peptides

23 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.3389%2FFNEUR.2015.00216

Effect of Sample Collection Tubes on Cerebrospinal Fluid Concentrations of Tau Proteins and Amyloid Peptides

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.3389%2FFNEUR.2015.00216

Differences and Similarities between Two Frequently Used Assays for Amyloid 42 in Cerebrospinal Fluid

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26528237

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3389/FNEUR.2015.00216

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

26528237

1 reference